Tessa DesRochers

Company: Kiyatec
Job title: Chief Scientific Officer
Seminars:
Ex Vivo Tumor Models for Drug Development and Clinical Testing 4:15 pm
• Understanding Kiyatec’s different ex vivo platforms • Application of ex vivo models throughout drug development, including immuno-oncology • Correlating ex vivo response to in vivo response in XPDX and the clinicRead more
day: Day One
Patient-Derived Tumor Models 4:45 pm
• Highlighting the different preclinical tumor models in use • Reviewing the reasons and context for use • Determining analysis strategies for combination efficacy and safetyRead more
day: Day One Track B PM 2